Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease

Tim S. Johnson*, Marie Fisher, John L. Haylor, Zoe Hau, N. James Skill, Richard Jones, Robert Saint, Ian G.C. Coutts, Melissa E Vickers, A. Meguid El Nahas, Martin Griffin

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology